Vienna, Austria - One of the largest studies to date looking at the impact of stent thrombosis and its treatment suggests that once thrombosis occurs, it matters very little whether the culprit was a ...

Intraprocedural stent thrombosis is a relatively rare complication of percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS), occurring less than 1% of of the time, ...

Please provide your email address to receive an email when new articles are posted on . PCI for in-stent chronic total occlusion had similar success rates and in-hospital complications compared with ...

In patients with three-vessel and/or left main coronary artery disease (CAD), percutaneous coronary intervention (PCI) with paclitaxel-eluting stents is equivalent to coronary artery bypass grafting ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For percutaneous ...

(HealthDay News) — For patients with multivessel coronary artery disease, percutaneous coronary intervention (PCI) with everolimus-eluting stents is linked to increased cardiovascular events vs.

Bivalirudin appears to carry an excess risk of stent thrombosis in the first 4 hours after primary PCI for STEMI compared with heparin with or without the use of glycoprotein IIb/IIIa inhibitors (GPIs ...

At 1 year, women experienced similar target lesion failure and ischemic outcomes compared with men after PCI with a dual-therapy stent, according to research published in Catheterization and ...

Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for ...